Rain Oncology Inc reports results for the quarter ended in June - Earnings Summary

Rain Oncology

11/08/2023 04:29

* Rain Oncology Inc  RAIN.OQ  reported a quarterly adjusted
loss
of 61 cents​​ per share for the quarter ended in June. The mean
expectation of eleven analysts for the quarter was for a loss
of 51 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Rain Oncology Inc's reported EPS for the quarter was a
loss
of 61 cents​.
    * The mean earnings estimate of analysts had risen by
about 7.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Rain Oncology Inc shares had risen by 0.8% this
quarter and
lost 84.9% so far this year.
    * The company reported a quarterly loss of $22.06 million.
    * Wall Street's median 12-month price target for Rain
Oncology Inc
is $1.88 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 10
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 11 at 03:29 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.51          -0.61          Missed
 Mar. 31 2023      -0.62          -0.56          Beat
 Dec. 31 2022      -0.56          -0.70          Missed
 Sep. 30 2022      -0.69          -0.68          Beat